ExploreWatchlistsPricing
  1. JP-listed companies
  2. ASKA Pharmaceutical Holdings CO., Ltd.
  3. Financials
  4. Cash from investing

ASKA Pharmaceutical Holdings CO., Ltd. (4886)

Market cap
¥76.3B
P/E ratio
15.7x
Asuka Pharmaceutical Holdings operates through subsidiaries that manufacture prescription drugs, veterinary medicines, and medical devices for healthcare providers globally.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 2026-5,752-6.07%
Mar 31, 2025-6,124-458.97%
Mar 31, 20241,706-251.51%
Mar 31, 2023-1,126-116.70%
Mar 31, 20226,743

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat